Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.20.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Jun. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Insurance premium obligation $ 261,625     $ 261,625  
Interest rate of insurance premium payable 5.27%     5.27%    
Patent and licensing costs $ 163,987 $ 362,755   $ 440,899 $ 672,661  
Concentration of risk, percentage 10.00% 10.00%   10.00% 10.00%  
Unrecognized tax benefits      
General and Administrative Expense [Member]            
Concentration of risk, percentage 20.40% 69.40%   32.70% 46.10%  
General and Administrative Expense [Member] | Stock Options granted to Three Corporate Officers [Member]            
Concentration of risk, percentage 49.10%     29.20%    
Research and Development Expense [Member] | Consultant [Member]            
Concentration of risk, percentage 87.70% 76.10%   75.20% 62.10%  
Research and Development Expense [Member] | Vendor [Member]            
Concentration of risk, percentage 15.30% 15.30%        
Research and Development Expense [Member] | Consultant and Vendor [Member]            
Concentration of risk, percentage       12.50% 10.00%  
Forecast [Member]            
Insurance premium to be paid     $ 29,767